ING Group’s BioNTech BNTX Stock Holding History

ING Group’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-430	Closed	-$46.4K	–	637
2023 Q2	$46.4K	Sell	430 -76	-15%	-$8.55K	﹤0.01%	507
2023 Q1	$63K	Buy	+506	New	+$69.5K	﹤0.01%	569
2022 Q1	–	Sell	-2,052	Closed	-$529K	–	534
2021 Q4	$529K	Buy	+2,052	New	+$562K	﹤0.01%	593

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

ING Group's BNTX Position: Q3 2023 in Review

ING Group sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 430 shares — an estimated $46.4K sold.

ING Group first reported a position in BNTX in Q4 2021 and held it in 3 quarters. The position peaked at $529K in Q4 2021. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

ING Group reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
ING Group sold 430 BioNTech shares in Q3 2023, an estimated $46.4K.
ING Group first reported a position in BioNTech in Q4 2021 and held it in 3 quarters.
ING Group's BioNTech position peaked at $529K in Q4 2021.
252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on ING Group's 13F filing for Q3 2023, filed 27 Oct 2023.